ES2067600T3 - Procedimiento para la fabricacion de preparados de inmunoglobulina, que contienen igm y/o iga, no modificados de administracion intravenosa. - Google Patents
Procedimiento para la fabricacion de preparados de inmunoglobulina, que contienen igm y/o iga, no modificados de administracion intravenosa.Info
- Publication number
- ES2067600T3 ES2067600T3 ES90114576T ES90114576T ES2067600T3 ES 2067600 T3 ES2067600 T3 ES 2067600T3 ES 90114576 T ES90114576 T ES 90114576T ES 90114576 T ES90114576 T ES 90114576T ES 2067600 T3 ES2067600 T3 ES 2067600T3
- Authority
- ES
- Spain
- Prior art keywords
- iga
- procedure
- manufacture
- modified
- intravenous administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
EL INVENTO SE REFIERE A UN PREPARADO DE INMUNOGLOBINA, QUE NO ESTA MODIFICADO QUIMICAMENTE, SE APLICA POR VIA INTRAVENOA, Y PRESENTA PEQUEÑAS ACTIVIDADES ANTICOMPLEMENTARIAS, Y SE COMPONE DON MAS DE UN 5% EN PESO DE IGMN Y CON MAS DE UN 10% EN PESO DE IGA Y DESCRIBE LA PRODUCCION DEL PREPARADO DE INMUNOGLOBINA A TRAVES DE CROMATOGRAFIA DE INTERCAMBIO DE ANIONES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3927111A DE3927111C3 (de) | 1989-08-17 | 1989-08-17 | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2067600T3 true ES2067600T3 (es) | 1995-04-01 |
Family
ID=6387263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90114576T Expired - Lifetime ES2067600T3 (es) | 1989-08-17 | 1990-07-30 | Procedimiento para la fabricacion de preparados de inmunoglobulina, que contienen igm y/o iga, no modificados de administracion intravenosa. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5410025A (es) |
EP (1) | EP0413188B1 (es) |
JP (1) | JP3148222B2 (es) |
AT (1) | ATE117900T1 (es) |
DE (2) | DE3927111C3 (es) |
DK (1) | DK0413188T3 (es) |
ES (1) | ES2067600T3 (es) |
GR (1) | GR3015229T3 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256771A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
DK0744957T3 (da) * | 1994-02-18 | 2000-03-06 | Immuno Ag | Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A |
US6685940B2 (en) | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
EP0835880A1 (de) * | 1996-10-14 | 1998-04-15 | Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk | Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation |
EP0852951A1 (de) | 1996-11-19 | 1998-07-15 | Roche Diagnostics GmbH | Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern |
US6955917B2 (en) * | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
US6441144B1 (en) * | 1999-05-20 | 2002-08-27 | Alpha Therapeutic Corporation | Method for repairing dual virally inactivated immune globulin for intravenous administration |
AU756071B2 (en) * | 1999-06-15 | 2003-01-02 | Grifols, Inc. | Manufacturing method for intravenous immune globulin and resultant product |
SE0001128D0 (sv) * | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
CA2423805A1 (en) * | 2000-09-28 | 2002-04-04 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
US20020098182A1 (en) * | 2000-09-28 | 2002-07-25 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
FR2824568B1 (fr) * | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
US20040180045A1 (en) * | 2001-09-28 | 2004-09-16 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
DE102007001521A1 (de) | 2007-01-10 | 2008-07-17 | Matthias, Torsten, Dr. | Verwendung von Cohn-Oncley-Fraktionen II und II/III zur Behandlung des systemischen Lupus erythematodes |
GB201006753D0 (en) * | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
JP2015510875A (ja) | 2012-03-09 | 2015-04-13 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | 分泌様免疫グロブリンを含む組成物 |
EP2636681A1 (en) * | 2012-03-09 | 2013-09-11 | CSL Behring AG | Process for enriching IgA |
US10570194B2 (en) * | 2015-08-06 | 2020-02-25 | Grifols Worldwide Operations Limited | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
US9913903B2 (en) | 2015-08-06 | 2018-03-13 | Grifols Worldwide Operations Limited | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
EP3275897A1 (en) | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
EP4132573A1 (en) * | 2020-04-10 | 2023-02-15 | Vanudis GmbH | Natural antibodies in prophylaxis and therapy |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3808189A (en) * | 1973-03-15 | 1974-04-30 | American Cyanamid Co | Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol |
DE2404265C3 (de) * | 1974-01-30 | 1980-05-29 | Behringwerke Ag, 3550 Marburg | Verfahren zum Abreichen von Immunglobulinen |
DE2527064C3 (de) * | 1975-06-18 | 1979-11-15 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität |
DE2835843A1 (de) * | 1978-08-16 | 1980-02-28 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung |
DE2901822A1 (de) * | 1979-01-18 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt |
DE3271181D1 (en) * | 1982-02-08 | 1986-06-19 | Schweiz Serum & Impfinst | Intravenously administrable human immunoglobuline and process for its preparation |
US4639513A (en) * | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
DE3310150A1 (de) * | 1983-03-21 | 1984-09-27 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation |
DE3426903A1 (de) * | 1984-07-20 | 1986-01-23 | Biotest Pharma GmbH, 6000 Frankfurt | Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten |
US4613501A (en) * | 1984-12-21 | 1986-09-23 | New York Blood Center, Inc. | Inactivation of viruses in labile blood derivatives |
NZ216094A (en) * | 1985-05-15 | 1989-06-28 | Commw Serum Lab Commission | Method for purification of an immunoglobulin |
US5159064A (en) * | 1986-04-08 | 1992-10-27 | Miles Inc. | Preparation of virus-free antibodies |
DE3640513A1 (de) * | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
-
1989
- 1989-08-17 DE DE3927111A patent/DE3927111C3/de not_active Expired - Lifetime
-
1990
- 1990-07-30 EP EP90114576A patent/EP0413188B1/de not_active Expired - Lifetime
- 1990-07-30 ES ES90114576T patent/ES2067600T3/es not_active Expired - Lifetime
- 1990-07-30 AT AT90114576T patent/ATE117900T1/de not_active IP Right Cessation
- 1990-07-30 DK DK90114576.3T patent/DK0413188T3/da active
- 1990-07-30 DE DE59008404T patent/DE59008404D1/de not_active Expired - Lifetime
- 1990-08-15 JP JP21445590A patent/JP3148222B2/ja not_active Expired - Fee Related
-
1993
- 1993-11-18 US US08/154,149 patent/US5410025A/en not_active Expired - Lifetime
-
1995
- 1995-02-28 GR GR950400435T patent/GR3015229T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE117900T1 (de) | 1995-02-15 |
DE59008404D1 (de) | 1995-03-16 |
DE3927111A1 (de) | 1991-02-21 |
EP0413188A3 (en) | 1991-06-05 |
JP3148222B2 (ja) | 2001-03-19 |
US5410025A (en) | 1995-04-25 |
DE3927111C3 (de) | 1994-09-01 |
DK0413188T3 (da) | 1995-03-27 |
DE3927111C2 (es) | 1991-11-28 |
JPH03204822A (ja) | 1991-09-06 |
GR3015229T3 (en) | 1995-05-31 |
EP0413188B1 (de) | 1995-02-01 |
EP0413188A2 (de) | 1991-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2067600T3 (es) | Procedimiento para la fabricacion de preparados de inmunoglobulina, que contienen igm y/o iga, no modificados de administracion intravenosa. | |
NO170126C (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat | |
SE8402560L (sv) | Farmaceutisk komposition | |
NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
ES2028796T3 (es) | Procedimiento para producir preparados farmaceuticos que contienen interferon alfa. | |
SE8406538D0 (sv) | Novel derivatives of purine | |
ATE30034T1 (de) | Immunglobulin-g-haeltige fraktion. | |
RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
KR900700132A (ko) | 면역 글로불린 e 반응 억제 방법 | |
OA07525A (fr) | Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés. | |
AU1615992A (en) | Use of protein c or activated protein c | |
FR2707638B1 (fr) | Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique. | |
IL72188A0 (en) | Imidazoquinazoline derivative and salts thereof,their preparation and pharmaceutical compositions containing them | |
FI910112A0 (fi) | Preparat foer lokalt bruk. | |
IE46171L (en) | N-pyrrolidinylmethylbenzamide derivative. | |
OA07270A (fr) | Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique. | |
NO162468C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater. | |
IT1237341B (it) | Trattamento dei disturbi allergici | |
AU545065B2 (en) | Pharmaceutical formulations containing prostaglandin | |
Kundu et al. | Reaction time, steadiness and neuroticism: A study of relationship. | |
Whiteside | Case study 2: The win-win bind. | |
DK134982A (da) | Fremgangsmaade til fremstilling af guanidinopyrimidiner | |
NO872504D0 (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 3,4-diamino-1,2,5-tiadiazolderivat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 413188 Country of ref document: ES |